A new consensus report, “Genomic Epidemiology Data Infrastructure Needs for SARS-CoV-2: Modernizing Pandemic Response Strategies,” from the National Academy of Sciences offers recommendations to address the SARS-CoV-2 pandemic through the integration of genomic, clinical and epidemiological data. The main focus of the report is how viral sequencing is being utilized to address COVID-19 and the […]

The water quality analysis and testing market’s role in improving water waste infrastructure on a global scale has shined a light on various issues related to the natural element. Access to clean water, government regulation addressing water pollution, extreme weather occurrences, and the attempt to update different region’s aging water infrastructure are some of the […]

As the number of biotech drugs in development grows exponentially, lab protein and cell purification workflows are facing increasing demand. Such workflows include clone selection, cell expansion studies and recombinant protein isolation prior to analysis. Suppliers of filtration and clarification consumables have responded by innovating to accelerate these workflows. Pall, one of the largest suppliers […]

The biopharmaceutical industry serves the world’s need for treatments for a wide range of illnesses. The bioprocessing sector is a key part of the biopharmaceutical industry, manufacturing biological drugs to ensure safety and effectiveness. The scientific instrument industry plays a vital role in the bioprocessing market, with companies offering analytical techniques and products that can […]

The National Instituts of Health (NIH) has released the “2020–2030 Strategic Plan for NIH Nutrition Research,” developed by the NIH Nutritional Research Task Force. The report calls for research investments in Precision Nutrition. Unlike personalized nutrition or nutrigenomcis, Precision Nutrituion encompasses both internal and external contributions: diet, genetics, physical health, microbiome, metabolism, dietary habits, activity […]

In the IBO blog’s fourth look at coronavirus-related R&D funding, the focus is on announcements made in May. Governments continue to make large commitments, with funding ultimately designated for universities, research institutes, the private sector, and infectious disease research organizations that will coordinate efforts to funnel money to all three sectors. These organizations include CEPI […]

Clinical diagnostic testing has been a major bottleneck throughout the global response to the COVID-19 pandemic, with severe shortages of testing reagents, lack or slow adaptation of existing infrastructure to administer tests, and very rapidly growing demand that is outpacing supply. The extraordinary demand for COVID-19 testing has strained the production capabilities of vendors in […]

The development of cell and gene therapies has become an essential component of cancer and genetic disease research and treatment. Consequently, regulatory approvals for cell and gene therapy have begun to increase globally. As a result, cell and gene therapy research has expanded into other areas of medicine, such as treatments for autoimmune and dermatological diseases.

This is the third of IBO’s review of R&D investments related to COVID-19 (see March 27 and April 17). The outbreak has triggered a wide range of responses spanning immediate and long-term solutions. For R&D, spending priorities range from areas  such as new diagnostic approaches and vaccine development to basic research in fields such as […]

The analytical and scientific instrument market in Europe is a compelling situation. According to IBO’s publisher Strategic Directions International (SDi) and part of Science and Medicine Group, prior to the COVID-19 pandemic, the industry’s recent performance in the region has been modest with periods of both enthusiastic and tepid demand. Despite the region’s strong presence […]